|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Targeted therapies in metastatic esophageal cancer: Advances over the past decade显示文摘 | Amr Mohamed Bassel El-Rayes Fadlo R. Khuri Nabil F. Saba | 2014 | Critical Reviews in Oncology / Hematology2014，，： | 2 |
| 2 | Comparison and Optimization of Multiplexed Quantum Dot-Based Immunohistofluorescence显示文摘Nanoparticle quantum dots (QDs) are ideal materials for multiplexed biomarker detection, localization, and quantification. Both direct and indirect methods are available for QD-based immunohistofluorescence (QD-IHF) staining;the direct method, however, has been considered laborious and costly. In this study, we optimized and compared the indirect QD-IHF single staining procedure using QD-secondary antibody conjugates and QD-streptavidin conjugates. Problems associated with sequential multiplex staining were identified quantitatively. A method using a QD cocktail solution was developed allowing simultaneous staining with three antibodies against E-cadherin, epidermal growth factor receptor and β-catenin in formalin-fixed and paraffin-embedded (FFPE) tissues. The expression of each biomarker was quantified by using the cocktail and the sequential methods. Comparison of the two methods demonstrated that the cocktail method provided more consistent and stable QD signals for each multiplexed biomarker than the sequential method, and provides a convenient tool for multiplexing biomarkers in both research and clinical applications. | Donghai Huang Xianghong Peng Ling Su Dongsheng Wang Fadlo R.Khuri Dong M.Shin Zhuo(Georgia)Chen | 2010 | Nano Research2010，3，1： | 2 |
| 3 | Cyclooxygenase -2 overexpression is a marker of poor prognosis in stage I non - small cell lung cancer 显示文摘 | Fadlo RK Hong WJ Jack L | 2001 | Clin Cancer Res2001，7，4： | 1 |
| 4 | Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implica-tion 显示文摘 | Jean C S Se J J Fadlo R K | 2000 | Cancer Rcs2000，60，1： | 1 |
| 5 | Targeted therapies in metastatic esophageal cancer: Advances over the past decade显示文摘 | Amr Mohamed Bassel El-Rayes Fadlo R. Khuri Nabil F. Saba | 2014 | Critical Reviews in Oncology / Hematology2014，，： | 1 |
| 6 | Mode of action of docetaxel-a basis for combination withnovel anticancer agents 显示文摘 | ROY SH FADLO RK | 2003 | Cancer Treat Rev2003，29，5： | 1 |
| 7 | Risk Factors for Rising Incidence of Esophageal and Gastric Cardia Adenocarcinoma显示文摘 | Jacquelyn S. Carr Syed F. Zafar Nabil Saba Fadlo R. Khuri Bassel F. El-Rayes | 2013 | Journal of Gastrointestinal Cancer2013，，2： | 1 |
| 8 | Overexpression of CyclinB1 in early-stage non-small cell lung cancer and its clinical implication显示文摘 | Jean-Charles Soria Se Jin Jang Fadlo R Khuri | 2000 | Cancer Research2000，60，： | 1 |
| 9 | Single agent maintenance therapy for advanced stage non-small cell lung cancer: A meta-analysis显示文摘 | Madhusmita Behera Taofeek K. Owonikoko Zhengjia Chen Scott A. Kono Fadlo R. Khuri Chandra P. Belani Suresh S. Ramalingam | 2012 | Lung Cancer2012，，2： | 1 |
| 10 | Loss of Fhit is fre-quent in stage I non-small cell lung cancer and in the lungs ofchronic smokers显示文摘 | Jennifer ET Bonnie LK Fadlo RK | 1999 | Cancer Res1999，59，19： | 1 |
| 11 | Perspectives forcancer prevention with natural compounds 显示文摘 | Ruhul Arm Omer K Fadlo R K | 2009 | J ClinOncol2009，27，16： | 1 |
| 12 | Gefitinib Versus Placebo in Completely Resected Non–Small-Cell Lung Cancer: Results of the NCIC CTG BR19 Study显示文摘 | Glenwood D. Goss Chris O’Callaghan Ian Lorimer Ming-Sound Tsao Gregory A. Masters James Jett Martin J. Edelman Rogerio Lilenbaum Hak Choy Fadlo Khuri Katherine Pisters David Gandara Kemp Kernstine Charles Butts Jonathan Noble Thomas A. Hensing Kendrith Ro | 2013 | Journal of Clinical Oncology2013，，27： | 1 |
| 13 | COX-2 over expression is a marker of poor prognosis in stage non-small cell lung cancer显示文摘 | Fadlo | 2001 | Lung cancer2001，7，： | 1 |
| 14 | Cyclooxygenase-2 overexpression is a marker of poor p rognosis in stage I non-small cell lung eancer显示文摘 | Fadlo R K Hong W J Jack L | 2001 | Clin Cancer Res2001，7，3： | 1 |
| 15 | Altered Glutamine Metabolism and Therapeutic Opportunities for Lung Cancer 显示文摘 | Amr Mohamed Xingming Deng Fadlo R | 2014 | Clinical Lung Cancer2014，15，1： | 1 |
| 16 | Paranasal sinus squamous cell carcinoma incidence and survival based on Surveillance, Epidemiology, and End Results Data, 1973 to 2009显示文摘 | Benjamin Ansa Michael Goodman Kevin Ward Scott A. Kono Taofeek K. Owonikoko Kristin Higgins Jonathan J. Beitler William Grist Trad Wadsworth Mark El‐Deiry Amy Y. Chen Fadlo Raja Khuri Dong M. Shin Nabil F. Saba | 2013 | Cancer2013，，14： | 1 |
| 17 | Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage Ⅰ non- small cell lung cancer 显示文摘 | FADLO R K HONG W J JACK L | 2001 | Clin Cancer Res2001，7，： | 1 |
| 18 | Overex-pression of cyclin B1 in early-stage non-small celllung cancer and its clillical implication 显示文摘 | Sofia Jean-Charles Jin Jang Se Fadlo R | 2000 | Cancer Res2000，60，： | 1 |
| 19 | Cyclooxygenase 2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer显示文摘 | Fadlo RK Hong WJ Jack L | 2001 | Clin Cancer Res2001，7，3： | 1 |
| 20 | Overex- pression of cyclin B1 in early - stage non - small cell lung cancer and its clillical implication 显示文摘 | Sofia Jean - Charles Jin Jang Se Fadlo R | 2000 | Cancer Res2000，60，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员